Associated Papers
USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer.
Nelson JK et al.
Nature Communications, 2022
35440539 (PubMed )
Supplement: 41467_2022_29684_MOESM1_ESM.pdf
Select a paper to view details